
Vertex Pharmaceuticals Incorporated
USD428.34
+3.25 (+0.76%)
CEO
Reshma Kewalramani
IPO Date
1991-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$420.01
Prev. Close
$425.09
Day Low
$420.01
Day High
$429.01
52W Low
$362.50
52W High
$507.92
Market Cap
$108.72B
Volume
1.32M
| 5 May 2026 |
| Bernstein |
| Outperform |
| Outperform |
| maintain |
| 5 May 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 30 Apr 2026 | Canaccord Genuity | Hold | Hold | maintain |
| 10 Apr 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 18 Mar 2026 | Maxim Group | Hold | Buy | upgrade |
| 11 Mar 2026 | Truist Securities | Buy | Buy | maintain |
| 10 Mar 2026 | B of A Securities | Buy | Buy | maintain |